From July 1, 2023 to September 30, 2023, the company has repurchased 1,200,664 shares, representing 0.95% for $1.29 million. With this, the company has completed the repurchase of 1,320,046 shares, representing 1.04% for $1.44 million under the buyback announced on June 27, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.49 USD | -11.83% | -10.24% | +69.32% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+69.32% | 187M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ATOS Stock
- News Atossa Therapeutics, Inc.
- Tranche Update on Atossa Therapeutics, Inc.'s Equity Buyback Plan announced on June 27, 2023.